As compared to DMSO treatment, chaetocin significantly suppressed the expression of CD44, GLI1, SOX2, and STAT3 in BCSCs and primary BC samples, in both mRNA (Figure 4E) and protein levels (Figures 4F,G). This evidence concerns the gene GLI1 and breast cancer.